NYSE · Stock
ABBV
AbbVie Inc.
254.04
Market closed · last price 1d ago
Last 24 hours
Bid
253.96
Ask
254.13
Day High
254.24
Day Low
251.34
ABBV key statistics
1 week
-1.52%
1 month
-4.40%
52w high
266.94
52w low
195.42
Avg daily range
+1.49%
History from
13 Aug 2025
Highs and lows are taken from 261 daily bars — the high was set on 28 Jul 2026 and the low on 29 Apr 2026. ABBV is quoted to 5 decimal places, minimum tick 0.00001, spread at last quote 0.17000, quoted in USD on NYSE, sourced from MetaTrader 5 (Broker 1).
ABBV daily history
| Date | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| 10 Sept 2026 | 252.28 | 254.51 | 251.50 | 254.06 | +0.71% |
| 09 Sept 2026 | 248.64 | 250.90 | 248.39 | 250.55 | +0.77% |
| 08 Sept 2026 | 252.60 | 254.54 | 249.28 | 249.42 | -1.26% |
| 04 Sept 2026 | 258.13 | 258.76 | 255.77 | 256.21 | -0.74% |
| 01 Sept 2026 | 261.32 | 261.81 | 257.88 | 259.08 | -0.86% |
| 31 Aug 2026 | 254.73 | 258.22 | 253.54 | 257.98 | +1.28% |
| 28 Aug 2026 | 257.09 | 257.96 | 255.13 | 255.84 | -0.48% |
| 27 Aug 2026 | 259.54 | 259.91 | 257.47 | 258.33 | -0.47% |
| 26 Aug 2026 | 263.37 | 263.47 | 260.40 | 262.72 | -0.25% |
| 20 Aug 2026 | 264.51 | 265.87 | 260.48 | 261.12 | -1.28% |
ABBV API access
AbbVie Inc. prices are available over REST and WebSocket with no API key and no signup. Rate limit is 15,000 requests per minute per IP.
curl
curl "https://biquote.io/api/ABBV"
Python
import requests
r = requests.get("https://biquote.io/api/ABBV")
tick = r.json()
print(tick["mid"], tick["dayDiffPercent"])JavaScript
const r = await fetch("https://biquote.io/api/ABBV");
const tick = await r.json();
console.log(tick.mid, tick.dayDiffPercent);WebSocket
// SignalR hub — pushes every tick for ABBV
const conn = new signalR.HubConnectionBuilder()
.withUrl("https://biquote.io/hubs/tick")
.build();
conn.on("ReceiveTick", t => console.log(t.symbol, t.mid));
await conn.start();
await conn.invoke("Subscribe", "ABBV");Also available for ABBV: daily candles, hourly candles · full API documentation
News about ABBV
- AbbVie (ABBV) Posted Positive Phase 3 Results For Menstrual Migraine Preventionsimplywall.st·10h ago
- ABBV Looks 15.8% Overvalued on GF Value™ as Dividend SustainabilGuruFocus·10h ago
- Is AbbVie (ABBV)’s $10.9 Billion Apogee Therapeutics (APGE) Deal the Next Catalyst for Growth?Yahoo Finance·1d ago
- AbbVie's ABBV-1480 Posts 90% Response Rate in Frontline NSCLC CombinationBioPharm International·3w ago
- Why Has AbbVie Gone Quiet About Humira?trefis.com·1d ago
- AbbVie Declares Quarterly DividendInvesting News Network·23h ago